4.7 Article

Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease

Journal

JOURNAL OF NEUROINFLAMMATION
Volume 11, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1742-2094-11-86

Keywords

PD; Neuroinflammation; Hsp60; Neurodegeneration; Microglia; Innate immunity

Funding

  1. Deutsche Forschungsgemeinschaft, (DFG), Germany
  2. Michael J Fox Foundation (MJFF)
  3. University Medical Center Giessen and Marburg (UKGM)
  4. Fondation pour la Recherche Medicale (FRM)
  5. Boehringer Ingelheim Fond (BIF)
  6. program 'Investissements d'avenir' [ANR-10-IAIHU-06]
  7. 'Poste Vert' (Accueil de Chercheurs Etrangers) from the Institut National de la Sante et de la Recherche Medicale (INSERM)

Ask authors/readers for more resources

Background: Increasing evidence suggests that inflammation associated with microglial cell activation in the substantia nigra (SN) of patients with Parkinson disease (PD) is not only a consequence of neuronal degeneration, but may actively sustain dopaminergic (DA) cell loss over time. We aimed to study whether the intracellular chaperone heat shock protein 60 (Hsp60) could serve as a signal of CNS injury for activation of microglial cells. Methods: Hsp60 mRNA expression in the mesencephalon and the striatum of C57/BL6 mice treated with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and the Hsp60/TH mRNA ratios in the SN of PD patients and aged-matched subjects were measured. To further investigate a possible link between the neuronal Hsp60 response and PD-related cellular stress, Hsp60 immunoblot analysis and quantification in cell lysates from SH-SY5Y after treatment with 100 mu M MPP+ (1-methyl-4-phenylpyridinium) at different time points (6, 12, 24 and 48 hours) compared to control cells were performed. Additional MTT and LDH assay were used. We next addressed the question as to whether Hsp60 influences the survival of TH+ neurons in mesencephalic neuron-glia cultures treated either with MPP+ (1 mu M), hHsp60 (10 mu g/ml) or a combination of both. Finally, we measured IL-1 beta, IL-6, TNF-alpha and NO-release by ELISA in primary microglial cell cultures following treatment with different hHsp60 preparations. Control cultures were exposed to LPS. Results: In the mesencephalon and striatum of mice treated with MPTP and also in the SN of PD patients, we found that Hsp60 mRNA was up-regulated. MPP+, the active metabolite of MPTP, also caused an increased expression and release of Hsp60 in the human dopaminergic cell line SH-SY5Y. Interestingly, in addition to being toxic to DA neurons in primary mesencephalic cultures, exogenous Hsp60 aggravated the effects of MPP+. Yet, although we demonstrated that Hsp60 specifically binds to microglial cells, it failed to stimulate the production of pro-inflammatory cytokines or NO by these cells. Conclusions: Overall, our data suggest that Hsp60 is likely to participate in DA cell death in PD but via a mechanism unrelated to cytokine release.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available